Clinical Trials Logo
  1. Home
  2. Hyperparathyroidism, Secondary
  3. NCT02830789

Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric Bypass

Hyperparathyroidism, Secondary Clinical Trial

Official title:
Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric Bypass in Order to Treat Secondary Hyperparathyroidism: A Clinical Randomized Trial

Clinical Trial Summary

This study investigates whether calcium citrate or calcium carbonate are the optimal supplement to treat secondary hyperparathyroidism following Roux-en-Y gastric bypass operation.

Half of the participants will be randomized to receive calcium citrate, while the other half will receive calcium carbonate. The study will be double blinded.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02830789
Study type Interventional
Source University of Aarhus
Contact
Status Completed
Phase N/A
Start date December 2016
Completion date May 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT01134562 - Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism Phase 1
Completed NCT02523209 - Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation N/A
Completed NCT01922843 - A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis Phase 2
Completed NCT01651000 - Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency Phase 3
Completed NCT00528788 - How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis Phase 4
Completed NCT01181531 - Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis Phase 4
Completed NCT05382988 - Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy Phase 3
Completed NCT02056730 - The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid Phase 4
Completed NCT01704079 - Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency Phase 3
Completed NCT00397475 - Evaluation of Colecalciferol Substitution in Dialysis Patients N/A
Withdrawn NCT03063190 - Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease Phase 4
Completed NCT02102204 - Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis Phase 3
Recruiting NCT02273570 - Optimal Anemia Treatment in End Stage Renal Disease (ERSD) N/A
Completed NCT01788046 - Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis Phase 3
Completed NCT01785849 - Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis Phase 3
Terminated NCT01277510 - Pediatric Chronic Kidney Disease Safety and Efficacy Phase 3
Terminated NCT01439867 - Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism Phase 2
Completed NCT01134549 - Safety, Tolerability and Pharmacokinetics of KAI-4169 in Healthy Male Volunteers Phase 1
Completed NCT01785875 - Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis Phase 3
Active, not recruiting NCT02464072 - Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under Dialysis N/A